Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Aptose Bioscns (APTO)

Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Aptose Reports Results for the Second Quarter 2022 Globe Newswire - Tue Aug 2, 2022

─ HM43239 Preliminary Response Rate of 43% Among R/R AML Patients with FLT3 Mutations Who Failed Prior Therapy with FLT3 inhibitors ─ ─ HM43239 Complete...

APTO : 0.7596 (+2.23%)
APS.TO : 1.00 (-2.91%)
Aptose to Present at the Canaccord Genuity 42nd Annual Growth Conference Globe Newswire - Wed Jul 27, 2022

SAN DIEGO and TORONTO, July 27, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage...

APTO : 0.7596 (+2.23%)
APS.TO : 1.00 (-2.91%)
Aptose to Report Second Quarter 2022 Financial Results and Hold Conference Call on Tuesday, August 2, 2022 Globe Newswire - Tue Jul 19, 2022

SAN DIEGO and TORONTO, July 19, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company...

APTO : 0.7596 (+2.23%)
APS.TO : 1.00 (-2.91%)
Aptose Appoints Fletcher Payne as Senior Vice President, Chief Financial Officer Globe Newswire - Mon Jun 27, 2022

SAN DIEGO and TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage...

APTO : 0.7596 (+2.23%)
APS.TO : 1.00 (-2.91%)
Aptose Appoints Fletcher Payne as Senior Vice President, Chief Financial Officer Globe Newswire - Mon Jun 27, 2022

SAN DIEGO and TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage...

APTO : 0.7596 (+2.23%)
APS.TO : 1.00 (-2.91%)
CORRECTION -- Aptose Presents Highlights from Corporate Update and KOL Event Globe Newswire - Thu Jun 2, 2022

HM43239 Delivers New Complete Remission at 160mg Dose in AML with Wildtype FLT3 New “G3” Formulation of Luxeptinib Demonstrates Encouraging PK Results ...

APTO : 0.7596 (+2.23%)
APS.TO : 1.00 (-2.91%)
Aptose Presents Highlights from Corporate Update and KOL Event Globe Newswire - Thu Jun 2, 2022

HM43239 Delivers New Complete Remission at 160mg Dose in AML with Wildtype FLT3 New “G3” Formulation of Luxeptinib Demonstrates Encouraging PK Results ...

APTO : 0.7596 (+2.23%)
APS.TO : 1.00 (-2.91%)
Aptose Biosciences Announces Results of Annual Meeting of Shareholders Globe Newswire - Tue May 31, 2022

SAN DIEGO and TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage...

APTO : 0.7596 (+2.23%)
APS.TO : 1.00 (-2.91%)
Aptose to Provide Program Updates at KOL Webinar on Thursday, June 2nd Globe Newswire - Wed May 25, 2022

Featuring distinguished hematology experts Brian Druker, M.D., Naval G. Daver, M.D. ...

APTO : 0.7596 (+2.23%)
APS.TO : 1.00 (-2.91%)
Aptose to Hold KOL Event and Corporate Update Thursday, June 2nd Globe Newswire - Thu May 12, 2022

Clinical Updates for HM43239 and Luxeptinib Poster Presentation for HM43239 is Scheduled for June 10th at EHA2022 Hybrid Congress SAN DIEGO and...

APTO : 0.7596 (+2.23%)
APS.TO : 1.00 (-2.91%)

Barchart Exclusives

Are These 3 Casino Stocks a Good Buy Now? Barchart - 11 minutes ago
Analysts rate all three casino stocks a “strong buy," and expect them to rally about 30% to 45%. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot